Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Social Security Benefits Up 4.0% to \75.04 Trillion
January 14, 2002
- Sumitomo Signs Contract on GPCR Database with LifeSpan
January 14, 2002
- Sanofi-Synthelabo to Consider Independent Marketing: Mr Fauchet
January 14, 2002
- BULLETIN
January 14, 2002
- REGULATORY NEWS IN BRIEF
January 14, 2002
- WORLD NEWS IN BRIEF
January 14, 2002
- Lipitor Shows Highest Growth in Sales: Top 100 Drugs
January 14, 2002
- DIAGNOSTIC NEWS IN BRIEF
January 14, 2002
- Otsuka Licenses Drug for Vitreous Body Hemorrhage from ISTA
January 14, 2002
- OTC NEWS IN BRIEF
January 14, 2002
- Asahi Glass Licenses ASPEX to Diversa
January 14, 2002
- Medical Fees to Decrease 1.3%
December 31, 2001
- POCT Market to Expand from 2003
December 31, 2001
- Price Discrepancy Rates Vary 5.7% to 9.6% According to Therapeutic Category
December 31, 2001
- WORLD NEWA IN BRIEF
December 31, 2001
- Chuikyo Recommends Price Cut for Long-listed Products
December 31, 2001
- Original Drugs with Generics Only to Be Subject to Additional Price Cut
December 31, 2001
- REGULATORY NEWS IN BRIEF
December 31, 2001
- Kissei, Novartis Make Alliance for Agent for Glaucoma
December 31, 2001
- Sankyo to Copromote CS-866 with Forest Laboratories in US
December 31, 2001
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…